Key facts
- nView Medical’s last known valuation is $30.1M (Aug 2025).
- It has raised $5.6M across 2 recorded rounds; the latest was Seed Round ($501K) in Feb 2018.
- Notable investors include US National Science Foundation, MedTech Innovator, Fusion Fund, BoomStartup, HealthTech Arkansas Programs — 12 tracked in total.
- nView Medical has filed 2 Form Ds with the SEC since 2018, most recently May 2019 ($1.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for nView Medical
Funding rounds
2 roundsAbout nView Medical
Developer of an artificial Intelligence-enabled medical imaging device designed to bring safety and accuracy to surgical procedures. The company's devices use artificial intelligence three-dimensional image creation algorithms that merge prior information with real-time data gathered during surgery to reduce imaging time and minimize X-ray radiation, enabling surgeons to operate on patients accurately, safely, and consistently.
- Sector
- Healthcare
- HQ
- Salt Lake City, UT, United States
- Founded
- 2012
- Employees
- 12
- Website
- nviewmed.com/
- Ownership
- Privately Held (backing)
nView Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in nView Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on nView Medical in its N-PORT filings yet. We sweep new filings monthly.